Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S14 (MRPS14) is a nuclear-encoded protein that is part of the 28S small subunit of the mitochondrial ribosome. It is essential for mitochondrial protein synthesis by facilitating mRNA recruitment and translation elongation within the mitochondria. Diseases caused by pathogenic variants in MRPS14 include combined oxidative phosphorylation deficiency, hypertrophic cardiomyopathy, and lactic acidosis. Although mitoribosomal proteins differ substantially from their prokaryotic homologs, MRPS14 belongs to the ribosomal protein S14P family and performs a structural and functional role within the mitochondrial ribosome. MRPS14 is not a classical drug target, but the mitoribosome as a whole has been implicated as a target in the context of certain antibiotics and investigational cancer therapies. Disruption of MRPS14 impairs energy production and mitochondrial homeostasis, leading to severe clinical manifestations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S14 (MRPS14).